The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evolution of biomarker testing in advanced non-small cell lung cancer (aNSCLC) and metastatic breast cancer (mBC) in U.S. community practices.
 
Lee S. Schwartzberg
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; BeyondSpring Pharmaceuticals; Coherus Biosciences; Genentech; GlaxoSmithKline; Helsinn Therapeutics; Illumina; Lilly; Mirati Therapeutics; Myriad Genetics; Napo Pharmaceuticals; Pfizer; Sanofi; Spectrum Pharmaceuticals
Speakers' Bureau - Coherus Biosciences; Merck; Puma Biotechnology; Seagen
 
Elaine Yu
Employment - Genentech
Stock and Other Ownership Interests - Genentech
 
Craig S. Meyer
Employment - Genentech
Stock and Other Ownership Interests - Genentech
 
Anuj Shah
Employment - Genentech
Stock and Other Ownership Interests - Genentech
Travel, Accommodations, Expenses - Genentech
 
Richard Price
Employment - Genentech/Roche
Stock and Other Ownership Interests - Genentech/Roche
Patents, Royalties, Other Intellectual Property - Healthcare technology patent (I)
 
Tania Szado
Employment - Genentech
Stock and Other Ownership Interests - Genentech/Roche; Moderna Therapeutics
 
Daniel A. Vaena
Honoraria - HMP
Consulting or Advisory Role - Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb/Celgene; Eisai; EMD Serono; Exelixis; Genomic Health; Immunomedics; natera; Seagen
Research Funding - Aeglea Biotherapeutics (Inst); AstraZeneca (Inst); BioClin Therapeutics (Inst); Blueprint Medicines (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Compugen (Inst); Compugen (Inst); incyte (Inst); Merck (Inst); Nektar (Inst); Novartis (Inst); OBI Pharma (Inst); Peloton Therapeutics (Inst); Roche/Genentech (Inst); Seagen (Inst); TG Therapeutics (Inst); Tizona Therapeutics, Inc. (Inst)
 
Davey B. Daniel
Employment - OneOncology
Leadership - OneOncology
Research Funding - Abbvie (Inst); Amgen (Inst); ARMO BioSciences (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Daiichi Sankyo (Inst); G1 Therapeutics (Inst); G1 Therapeutics (Inst); Genentech (Inst); Genentech (Inst); Genentech (Inst); Genentech (Inst); Genentech (Inst); Guardant Health (Inst); Immunomedics (Inst); Janssen Research & Development (Inst); Lilly (Inst); Merck (Inst); Merus NV (Inst); Novartis (Inst); Novartis (Inst); Roche (Inst); Roche (Inst); Roche (Inst)
 
Dennis Slater
No Relationships to Disclose
 
Harry Staszewski
No Relationships to Disclose
 
Bruno Fang
Employment - Astera Cancer Care; Regional Cancer Care Associates; Regional Cancer Care Associates
Leadership - Astera Cancer Care; Regional Cancer Care Associates
Research Funding - Abbvie; Arvinas; Bristol-Myers Squibb/Pfizer; Daiichi Sankyo/Astra Zeneca; Epizyme; Exelixis; Gilead/Forty Seven; ImmunityBio; Janssen Oncology; Mirati Therapeutics; natera; Novartis; Novocure; POINT Biopharma; Roche/Genentech; Veru; Zymeworks; Zymeworks
 
Lasika Seneviratne
No Relationships to Disclose
 
Esprit Ma
Employment - Genentech
Stock and Other Ownership Interests - Genentech